Interleukin-6 predicts inflammation-induced increase of Glucagon-like peptide-1 in humans in response to cardiac surgery with association to parameters of glucose metabolism
出版年份 2016 全文链接
标题
Interleukin-6 predicts inflammation-induced increase of Glucagon-like peptide-1 in humans in response to cardiac surgery with association to parameters of glucose metabolism
作者
关键词
GLP-1, IL6, Inflammation, Insulin secretion, Cardiac surgery, Inflammatory response
出版物
Cardiovascular Diabetology
Volume 15, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-02-03
DOI
10.1186/s12933-016-0330-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gliptin and GLP‐1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide‐induced endotoxemia
- (2015) Sebastian Steven et al. BASIC RESEARCH IN CARDIOLOGY
- The Effects of TNF-α on GLP-1-Stimulated Plasma Glucose Kinetics
- (2015) Louise Lehrskov-Schmidt et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The protective effect of the Mediterranean diet on endothelial resistance to GLP-1 in type 2 diabetes: a preliminary report
- (2014) Antonio Ceriello et al. Cardiovascular Diabetology
- The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms
- (2014) Yanmei Zeng et al. Cardiovascular Diabetology
- GLP-1 Secretion Is Increased by Inflammatory Stimuli in an IL-6-Dependent Manner, Leading to Hyperinsulinemia and Blood Glucose Lowering
- (2014) F. Kahles et al. DIABETES
- Simultaneous GLP-1 and Insulin Administration Acutely Enhances Their Vasodilatory, Antiinflammatory, and Antioxidant Action in Type 2 Diabetes
- (2014) Antonio Ceriello et al. DIABETES CARE
- Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetes
- (2014) André J. Tremblay et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Inflammation, Cytokines and Insulin Resistance: A Clinical Perspective
- (2013) Verena Wieser et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans
- (2013) Katja Piotrowski et al. Cardiovascular Diabetology
- The Glucoregulatory Benefits of Glucagon-Like Peptide-1 (7-36) Amide Infusion During Intensive Insulin Therapy in Critically Ill Surgical Patients
- (2013) Panagis Galiatsatos et al. CRITICAL CARE MEDICINE
- Acute peripheral administration of synthetic human GLP-1 (7–36 amide) decreases circulating IL-6 in obese patients with type 2 diabetes mellitus: A potential role for GLP-1 in modulation of the diabetic pro-inflammatory state?
- (2013) Christina Daousi et al. REGULATORY PEPTIDES
- Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
- (2011) Helga Ellingsgaard et al. NATURE MEDICINE
- Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: Relationship to glycemia*
- (2010) Adam M. Deane et al. CRITICAL CARE MEDICINE
- Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
- (2010) M. Arakawa et al. DIABETES
- Glucose Metabolism and Insulin Resistance in Sepsis
- (2008) S. Van Cromphaut et al. CURRENT PHARMACEUTICAL DESIGN
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started